Equities

Lisata Therapeutics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Lisata Therapeutics Inc

Actions
  • Price (USD)4.57
  • Today's Change0.00 / 0.00%
  • Shares traded347.00
  • 1 Year change+76.25%
  • Beta1.2689
Data delayed at least 20 minutes, as of Feb 17 2026 18:54 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, cash reserves at Lisata Therapeutics Inc fell by 6.38m. However, Cash Flow from Investing totalled 13.23m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 19.36m for operations while cash used for financing totalled 206.00k.
Cash flow per share-2.10
Price/Cash flow per share--
Book value per share1.98
Tangible book value per share1.97
More ▼

Balance sheet in USDView more

Lisata Therapeutics Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio4.72
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.